Soleus Capital Management, L.P. Protara Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$13.75 - $23.86 $221,278 - $383,978	-16,093 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.97 - $25.34 $1.42 Million - $2.13 Million	-83,907 Reduced 83.91%	16,093 $390,000
Q3 2020 Nov 13, 2020	BUY	$16.76 - $31.89 $1.68 Million - $3.19 Million	100,000 New	100,000 $1.68 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $53M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.